• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

misiu143's Profile

Avatar:

Membership:

Premium

Person Marks:

37

Total Posts:

4445

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

1

Alias Born

08/27/2015 5:02:34 PM

Personal info

Recent Articles

• Lincoln Educational Services Showcases Robust Q1 Growth
• Anixa Biosciences Showcases Breakthrough Ovarian Cancer Research
• Aarki Unveils Encore: Revolutionizing Mobile Marketing Growth
• Collegium Pharmaceutical Announces Exciting Share Buyback Plan
• Apexon Partners with Dataiku to Drive AI Innovation Forward
• Nature's Path Unveils Brother Nature: A New Organic Movement
• IMUNON Reveals Promising Financial Progress and Updates
• NRx Pharmaceuticals to Share Key Financial Insights Soon
• Healthy Choice Wellness Corp. Reports Impressive Q1 Growth
• Lamina Partners with nCino to Transform Loan Workflows
• Bitget's Humanitarian Efforts in Myanmar After Earthquake
• PNC Bank Launches Spend Wise Credit Card to Promote Financial Wellbeing
• ZA Miner Launches Innovative Bitcoin Mining Solution
• Genpact's Leadership in ServiceNow Ecosystem Solutions
• CervoMed's Q1 Financial Update: Progress in Neurological Trials
• Pearson PLC Announces New Share Options for Management Personnel
• Quantum BioPharma Completes Key Toxicity Studies for MS Drug
• Gstar Subic Unveils First High-Efficiency N-Type Module
• Annexon, Inc. Advances Key Therapies and Reports Q1 Results
• DeFi Development Corp. Expands SOL Holdings Beyond $100 Million
• Enphase Energy Launches Innovative Balcony Solar System in Belgium
• Opus Genetics Showcases Groundbreaking Findings at Key Conferences
• Oxford Lane Capital Corp. Prepares for Q4 Earnings Call Soon
• Galectin Therapeutics Unveils NAVIGATE Study Findings at EASL 2025
• Gabelli Funds Announces Insightful Media & Entertainment Event
• CPS Technologies Set for Engagement at Upcoming Conference
• Longevity Health Holdings Implements 1-for-30 Reverse Split
• Esperion Advances in Patent Settlement, Securing NEXLETOL® Market
• Windtree Therapeutics Unveils Key Findings on Istaroxime
• ProStar and JAVAD GNSS Team Up for Innovative Mapping Solutions
• Shai Lankry Joins Purple Biotech as New CFO Driving Growth
• Strategic Moves by Neinor Homes to Monetize BTR Portfolio
• LNG Energy Group Faces Cease Trade Order Amid Filing Delay
• OSB Group's Management Shareholding Notification Explained
• Solo Brands, Inc. Reports First Quarter Financial Results
• PyroGenesis Secures $2.39 Million in Initial Loan Tranche
• Hong Kong Jockey Club Aims for Global Entertainment Hub
• Gain Therapeutics Unveils Promising Data on GT-02287's Potential
• Curaleaf International's Innovative Device Transforms Cannabis Care
• BridgeBio Highlights Groundbreaking Results on Heart Health
• Surgery Partners' Q1 2025: Growth Continues Amid Challenges
• Bread Financial's Commitment to Sustainability Exemplified in 2024 Report
• Abeona Therapeutics Finalizes Agreement for $155 Million Sale
• Insights from Tallinna Sadam's Recent Investor Webinar
• Clearmind Medicine Strengthens IP With New European Patent
• Innovative Psychedelic Therapy for Cocaine Addiction Unveiled
• Inter&Co Inc. Achieves Impressive 57% Net Income Growth
• Aclarion Welcomes Texas Back Institute to CLARITY Trial Network
• Alterity Therapeutics Advances Neurological Treatments Through Innovation
• Insights on Management Trading Activities and Their Impact